Vetoquinol (VETO)

Paris
Currency in EUR
73.30
-0.40(-0.54%)
Closed
VETO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
73.3074.20
52 wk Range
63.60106.20
Key Statistics
Edit
Prev. Close
73.7
Open
74.1
Day's Range
73.3-74.2
52 wk Range
63.6-106.2
Volume
5.23K
Average Volume (3m)
3.27K
1-Year Change
-27.71%
Book Value / Share
45.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VETO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
93.43
Upside
+27.46%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
  • Vetoquinol: Annual Sales 2024
    • Investing.com
  • Vetoquinol: Sales at End September 2024
    • Investing.com
  • Vetoquinol: 2024 Half-year Results
    • Investing.com
Show more

Vetoquinol Company Profile

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Employees
2519
Market
France

Compare VETO to Peers and Sector

Metrics to compare
VETO
Peers
Sector
Relationship
P/E Ratio
18.4x16.7x−0.6x
PEG Ratio
−0.930.030.00
Price/Book
1.6x2.2x2.6x
Price / LTM Sales
1.6x2.9x3.1x
Upside (Analyst Target)
22.1%29.3%52.1%
Fair Value Upside
Unlock6.3%8.2%Unlock

Analyst Ratings

3 Buy
4 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 93.43
(+27.46% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.98
Dividend Yield
1.16%
Industry Median 3.76%
Annualised payout
0.8500
Paid annually
5-Years Growth
+12.11%
Growth Streak

Earnings

Latest Release
Oct 30, 2024
EPS / Forecast
-- / --
Revenue / Forecast
133.70M / 138.80M
EPS Revisions
Last 90 days

People Also Watch

65.61
LOUP
-0.86%
83.70
CCHE
-1.88%
5.700
GTCN
-2.73%
21.95
MANP
-2.01%
313.50
VIRB
-0.95%

FAQ

What Is the Vetoquinol (VETO) Stock Price Today?

The Vetoquinol stock price today is 73.30

What Stock Exchange Does Vetoquinol Trade On?

Vetoquinol is listed and trades on the Paris stock exchange.

What Is the Stock Symbol for Vetoquinol?

The stock symbol for Vetoquinol is "VETO."

Does Vetoquinol Pay Dividends? What’s The Current Dividend Yield?

The Vetoquinol dividend yield is 1.16%.

What Is the Vetoquinol Market Cap?

As of today, Vetoquinol market cap is 867.32M.

What is Vetoquinol Earnings Per Share?

The Vetoquinol EPS is 3.98.

What Is the Next Vetoquinol Earnings Date?

Vetoquinol will release its next earnings report on 20 Mar 2025.

From a Technical Analysis Perspective, Is VETO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.